Free Trial

ConvaTec Group (CTEC) Competitors

ConvaTec Group logo
GBX 235.80 +5.20 (+2.25%)
(As of 11/22/2024 ET)

CTEC vs. AMS, TSTL, BVC, SPEC, AKR, CNSL, ODX, SN, DPH, and HIK

Should you be buying ConvaTec Group stock or one of its competitors? The main competitors of ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), Smith & Nephew (SN), Dechra Pharmaceuticals (DPH), and Hikma Pharmaceuticals (HIK). These companies are all part of the "medical" sector.

ConvaTec Group vs.

ConvaTec Group (LON:CTEC) and Advanced Medical Solutions Group (LON:AMS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.

Advanced Medical Solutions Group has a net margin of 8.49% compared to ConvaTec Group's net margin of 6.96%. ConvaTec Group's return on equity of 9.34% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group6.96% 9.34% 5.01%
Advanced Medical Solutions Group 8.49%4.59%2.35%

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.20B2.20£153.20M£0.063,930.00
Advanced Medical Solutions Group£131.11M3.43£11.13M£0.054,190.00

ConvaTec Group pays an annual dividend of GBX 5 per share and has a dividend yield of 2.1%. Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. ConvaTec Group pays out 8,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 4,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

69.1% of ConvaTec Group shares are owned by institutional investors. Comparatively, 58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. 19.7% of ConvaTec Group shares are owned by company insiders. Comparatively, 3.1% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ConvaTec Group has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Advanced Medical Solutions Group has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.

In the previous week, ConvaTec Group and ConvaTec Group both had 1 articles in the media. ConvaTec Group's average media sentiment score of 0.75 beat Advanced Medical Solutions Group's score of 0.54 indicating that ConvaTec Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ConvaTec Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Advanced Medical Solutions Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

ConvaTec Group currently has a consensus price target of GBX 301.67, indicating a potential upside of 27.93%. Advanced Medical Solutions Group has a consensus price target of GBX 300, indicating a potential upside of 43.20%. Given Advanced Medical Solutions Group's higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than ConvaTec Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

ConvaTec Group received 191 more outperform votes than Advanced Medical Solutions Group when rated by MarketBeat users. Likewise, 66.79% of users gave ConvaTec Group an outperform vote while only 49.85% of users gave Advanced Medical Solutions Group an outperform vote.

CompanyUnderperformOutperform
ConvaTec GroupOutperform Votes
356
66.79%
Underperform Votes
177
33.21%
Advanced Medical Solutions GroupOutperform Votes
165
49.85%
Underperform Votes
166
50.15%

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTEC vs. The Competition

MetricConvaTec GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£4.83B£2.62B£5.38B£1.61B
Dividend Yield2.23%2.01%5.13%11.49%
P/E Ratio3,930.00341.35102.461,643.75
Price / Sales2.20157.661,234.85250,554.96
Price / Cash17.01134.5840.4725.38
Price / Book2.912.827.092.89
Net Income£153.20M£84.03M£119.65M£172.88M
7 Day Performance-4.18%-1.99%2.06%-0.02%
1 Month Performance5.55%-3.45%-2.46%-0.42%
1 Year Performance3.69%-0.98%33.95%25.04%

ConvaTec Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTEC
ConvaTec Group
2.5425 of 5 stars
GBX 235.80
+2.3%
GBX 301.67
+27.9%
+4.2%£4.83B£2.20B3,930.0010,000
AMS
Advanced Medical Solutions Group
2.34 of 5 stars
GBX 204.50
flat
GBX 300
+46.7%
-0.7%£438.76M£131.11M4,110.0010Gap Down
TSTL
Tristel
N/AGBX 441.80
+0.4%
N/A+3.1%£210.52M£39.49M3,388.46208
BVC
BATM Advanced Communications
N/AGBX 19.25
-1.0%
N/A-11.5%£83.97M£122.70M2,800.00980News Coverage
SPEC
INSPECS Group
N/AGBX 51.89
-3.9%
N/A-40.6%£52.76M£195.14M-16.901,673
AKR
Akers Biosciences
N/AGBX 57.50
flat
N/A+0.0%£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.20
+1.6%
N/AN/A£7.61M£9.77M-362.103,200Gap Up
ODX
Omega Diagnostics Group
N/AGBX 2.20
flat
N/A+0.0%£5.23M£7.55M-220.0091Gap Down
SN
Smith & Nephew
3.6777 of 5 stars
GBX 976
+0.1%
GBX 3,956.20
+305.3%
-4.5%£8.51B£5.64B3,610.3718,452High Trading Volume
DPH
Dechra Pharmaceuticals
N/AGBX 3,866
flat
N/A+1.2%£4.40B£761.50M-15,464.002,457
HIK
Hikma Pharmaceuticals
1.7462 of 5 stars
GBX 1,926
+2.9%
GBX 2,383.33
+23.7%
+11.0%£4.27B£3.02B2,880.009,100

Related Companies and Tools


This page (LON:CTEC) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners